Parameter | Patients(n = 14) |
---|---|
Glomerular abnormalities, n(%) | 14(100%) |
Glomerulosclerosis | |
Mild(< 20%), n(%) | 3(21.4%) |
Moderate(20-40%), n(%) | 3(21.4%) |
Severe(> 40%), n(%) | 8(57.1%) |
Increased mesangial matrix, n(%) | 13(92.9%) |
Specific glomerular lesions | |
Focal segmental glomurulosclerosis, n(%) | 10(71.4%) |
Membranoproliferative glomerulonephritis, n(%) | 3(21.4%) |
Glomerular microangiopathy | 1(7.1%) |
Cresents, n(%) | 2(14.3%) |
<50%, n(%) | 1(7.1%) |
≥50%, n(%) | 1(7.1%) |
Arterial abnormalities, n(%) | 13(92.9%) |
Tubulointerstitial abnormalities | 14(100%) |
Mild(< 25%), n(%) | 2(14.3%) |
Moderate(25-50%), n(%) | 3(21.4%) |
Moderate to Severe(50–75%) | 3(21.4%) |
Severe(> 75%), n(%) | 6(42.9%) |
Interstitial fibrosis, n(%) | 13(92.9%) |
Immunofluorescence abnormalities, of glomuruli, n(%) | 10(92.9%) |
IgA positive, n(%) | 9(64.3%) |
IgM positive, n(%) | 6(42.0%) |
IgG positive, n(%) | 1(7.1%) |
C3 positive, n(%) | 8(57.1%) |
C1q positive, n(%) | 3(21.4%) |